Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hour continuous infusion weekly for three weeks in metastatic colorectal carcinoma
暂无分享,去创建一个
D. Moore | S. Arbuck | R. Winn | R. Pazdur | S. Dakhil | J. Abbruzzese | P. Hoff | A. Scalzo | D. Medgyesy